News archives

Home > News archives

NBHL will attend BIO-Europe 2019 in Hamburg, Germany.

Nov 8,2019 -- Updated 09:47 +0900 (GMT)

NBHL will be at “BIO-Europe 2019” to be held in Hamburg, Germany, from November 11th to 13th, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event and would like to meet you there.

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

NBHL will attend BIO Investor Forum 2019 in San Francisco, USA

Oct 21,2019 -- Updated 18:00 +0900 (GMT)

NBHL will be at the BIO Investor Forum 2019 to be held in San Francisco from October 22nd to 23rd, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event. We will make a short presentation on the new MoGRAA® discovery engine powered by the innovative high-throughput single-cell technology RiGRASSTM for discovering anti-GPCR antibodies and our antibody pipelines. This presentation is scheduled from 3:15 to 3:30 pm on October 22nd. We are looking forward to meeting you in San Francisco to discuss future opportunities. 

For more information on this event, please visit https://www.bio.org/events/bio-investor-forum

 

NBHL to present at the FESTIVAL OF BIOLOGICS 2019 in Basel, Switzerland

Oct 15,2019 -- Updated 10:23 +0900 (GMT)

Kiyoshi Takayama (President, NBHL) will give a presentation at the FESTIVAL OF BIOLOGICS 2019 to be held in Basel, Switzerland, from October 15th to 17th, 2019. He will chair the Technology Showcase session on October 15th. Looking forward to meeting you in Basel to discuss future opportunities.

[Date of Presentation]

October 16th, 2019 (Start time: 11:25 am)

[Venue]

Basel Congress Centre

[Session]

Technology Showcase

[Presentation Title]

MoGRAA® discovery engine to generate the functional therapeutic mAbs targeting GPCRs with a unique single cell analysis technique

[URL]

https://www.terrapinn.com/conference/festival-of-biologics/index.stm

 

NBHL will be present at BioJapan 2019 in Yokohama, Japan

Oct 8,2019 -- Updated 17:22 +0900 (GMT)

NBHL will have a panel exhibition at C-06 (in Hokkaido Bio Cluster booth) in “BioJapan 2019” to be held in Pacifico Yokohama, Japan, from October 9th to 11th, 2019. Kiyoshi Takayama (CEO, NBHL) will make a short presentation on “RiGRASSTMan innovative high-throughput single-cell technology for discovering anti-GPCR antibodies.” This presentation is scheduled at Exhibitor’s Stage I from 14:35 to 14:45 on October 11th. We are looking forward to meeting you in Yokohama.

For more information on this event, please visit https://www.ics-expo.jp/biojapan/en/

 

NBHL will attend Discovery on Target 2019 in Boston, USA.

Sep 11,2019 -- Updated 17:30 +0900 (GMT)

NBHL will be at Discovery on Target 2019 to be held in Boston from September 16th to 19th, 2019. Kiyoshi Takayama (President, NBHL) will make a poster presentation on our new single-cell technology for GPCR antibody production.

 NB Health Laboratory Co. Ltd.

Poster #164. Discovery of the Functional Therapeutic mAbs Targeting GPCRs with a Unique Single Cell Analysis Technique

 For more information on this event, please visit https://www.discoveryontarget.com/

 

NBHL will attend 2019 BIO International Convention in Philadelphia, USA.

May 28,2019 -- Updated 17:16 +0900 (GMT)

NBHL will be at “2019 BIO International Convention” to be held in Philadelphia from June 3rd to 6th, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event. Please visit our booth located in Japan Pavilion(booth #1509). We are looking forward to meeting you in Philadelphia to discuss future opportunities.

 

For more information on this event, please visit  <https://convention.bio.org/2019/>

NBHL will present as a guest speaker in Research Xchange Seminar Tokyo 2019

May 13,2019 -- Updated 19:02 +0900 (GMT)

“Research Xchange Seminar Tokyo 2019: Cell analysis to accelerate oncology/immuno-oncology” will be held on May 23rd, 2019. Kiyoshi Takayama (President, NBHL) will make a presentation on “Screening of GPCR-targeted monoclonal antibodies using iQue® Screener.”

For more information on this seminar, please visit

https://sartorius-if.smktg.jp/public/seminar/view/17

NBHL will attend BIO-Europe Spring 2019 in Vienna, Austria.

Mar 25,2019 -- Updated 09:43 +0900 (GMT)

NBHL will be at “BIO-Europe Spring 2019” to be held in Vienna, Austria, from March 25th to 27th, 2019. Our Business Development team will attend this exciting event and would like to meet you there.

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope-spring/

NBHL to present at PHAR-EAST 2019 in Sentosa Island, Singapore

Mar 14,2019 -- Updated 11:30 +0900 (GMT)

NBHL will be at PHAR-EAST 2019 (Asia’s Pharma & Biotech Festival) to be held in Sentosa Island, Singapore, from March 18th to 20th, 2019. Kiyoshi Takayama (President, NBHL) will make a short presentation on “MoGRAA® discovery engine”, our technology platform for the discovery of functional monoclonal antibody therapeutics targeting GPCRs and our antibody pipeline at Biotech Pitch in the event.

For more information on this event, please visit https://www.terrapinn.com/exhibition/phar-east/speaker-kiyoshi-TAKAYAMA.stm

NBHL will attend BIO-Europe 2018 in Copenhagen, Denmark.

Oct 23,2018 -- Updated 17:18 +0900 (GMT)

NBHL will be at “BIO-Europe 2018” to be held in Copenhagen, Denmark, from November 5th to 7th, 2018. Kiyoshi Takayama (CEO, NBHL) will attend this exciting event and would like to meet you there.

 

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

次へ »